Psychometric properties of the children's depression rating Scale-Revised in adolescents

Taryn L. Mayes, Ira H. Bernstein, Charlotte L. Haley, Betsy D. Kennard, Graham J. Emslie

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Objective: The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group. Method: Adolescents with symptoms of depression were assessed using the CDRS-R and global severity and functioning scales at screening, baseline, and after 12 weeks of fluoxetine treatment. Global improvement was also assessed at week 12 (or exit). Reliability and validity were analyzed using Classical Test Theory (item-total correlations and internal consistency) and correlations between the CDRS-R and other outcomes. Results: Adolescents (n=145) were evaluated at screening; 113 (77.9%) met criteria for major depressive disorder, 8 (5.5%) had subthreshold depressive symptoms, and 24 (16.6%) had minimal depressive symptoms. Ninety-four adolescents had a baseline visit after 1 week, and 88 were treated with fluoxetine. Internal consistency for the CDRS-R was good at all three visits (screening: 0.79; baseline: 0.74; exit: 0.92), and total score was highly correlated with global severity (r=0.87, 0.80, and 0.93; p<0.01). Only exit CDRS-R score was significantly correlated with global functioning (Children's Global Assessment Scale; r=-0.77; p<0.01). Reductions on the CDRS-R total score were highly correlated with improvement scores at exit (Clinical Global Impressions-Improvement; r=-0.83; p<0.01). Conclusions: The results demonstrate good reliability and validity in adolescents with depression.

Original languageEnglish (US)
Pages (from-to)513-516
Number of pages4
JournalJournal of Child and Adolescent Psychopharmacology
Volume20
Issue number6
DOIs
StatePublished - Dec 1 2010

Fingerprint

Psychometrics
Depression
Reproducibility of Results
Fluoxetine
Major Depressive Disorder
Age Groups

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health

Cite this

Psychometric properties of the children's depression rating Scale-Revised in adolescents. / Mayes, Taryn L.; Bernstein, Ira H.; Haley, Charlotte L.; Kennard, Betsy D.; Emslie, Graham J.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 20, No. 6, 01.12.2010, p. 513-516.

Research output: Contribution to journalArticle

@article{b4e4d0b7c02d475187531c04c37d54c2,
title = "Psychometric properties of the children's depression rating Scale-Revised in adolescents",
abstract = "Objective: The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group. Method: Adolescents with symptoms of depression were assessed using the CDRS-R and global severity and functioning scales at screening, baseline, and after 12 weeks of fluoxetine treatment. Global improvement was also assessed at week 12 (or exit). Reliability and validity were analyzed using Classical Test Theory (item-total correlations and internal consistency) and correlations between the CDRS-R and other outcomes. Results: Adolescents (n=145) were evaluated at screening; 113 (77.9{\%}) met criteria for major depressive disorder, 8 (5.5{\%}) had subthreshold depressive symptoms, and 24 (16.6{\%}) had minimal depressive symptoms. Ninety-four adolescents had a baseline visit after 1 week, and 88 were treated with fluoxetine. Internal consistency for the CDRS-R was good at all three visits (screening: 0.79; baseline: 0.74; exit: 0.92), and total score was highly correlated with global severity (r=0.87, 0.80, and 0.93; p<0.01). Only exit CDRS-R score was significantly correlated with global functioning (Children's Global Assessment Scale; r=-0.77; p<0.01). Reductions on the CDRS-R total score were highly correlated with improvement scores at exit (Clinical Global Impressions-Improvement; r=-0.83; p<0.01). Conclusions: The results demonstrate good reliability and validity in adolescents with depression.",
author = "Mayes, {Taryn L.} and Bernstein, {Ira H.} and Haley, {Charlotte L.} and Kennard, {Betsy D.} and Emslie, {Graham J.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1089/cap.2010.0063",
language = "English (US)",
volume = "20",
pages = "513--516",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Psychometric properties of the children's depression rating Scale-Revised in adolescents

AU - Mayes, Taryn L.

AU - Bernstein, Ira H.

AU - Haley, Charlotte L.

AU - Kennard, Betsy D.

AU - Emslie, Graham J.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Objective: The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group. Method: Adolescents with symptoms of depression were assessed using the CDRS-R and global severity and functioning scales at screening, baseline, and after 12 weeks of fluoxetine treatment. Global improvement was also assessed at week 12 (or exit). Reliability and validity were analyzed using Classical Test Theory (item-total correlations and internal consistency) and correlations between the CDRS-R and other outcomes. Results: Adolescents (n=145) were evaluated at screening; 113 (77.9%) met criteria for major depressive disorder, 8 (5.5%) had subthreshold depressive symptoms, and 24 (16.6%) had minimal depressive symptoms. Ninety-four adolescents had a baseline visit after 1 week, and 88 were treated with fluoxetine. Internal consistency for the CDRS-R was good at all three visits (screening: 0.79; baseline: 0.74; exit: 0.92), and total score was highly correlated with global severity (r=0.87, 0.80, and 0.93; p<0.01). Only exit CDRS-R score was significantly correlated with global functioning (Children's Global Assessment Scale; r=-0.77; p<0.01). Reductions on the CDRS-R total score were highly correlated with improvement scores at exit (Clinical Global Impressions-Improvement; r=-0.83; p<0.01). Conclusions: The results demonstrate good reliability and validity in adolescents with depression.

AB - Objective: The aim of this study was to present the reliability and validity of the Children's Depression Rating Scale-Revised (CDRS-R) in the adolescent age group. Method: Adolescents with symptoms of depression were assessed using the CDRS-R and global severity and functioning scales at screening, baseline, and after 12 weeks of fluoxetine treatment. Global improvement was also assessed at week 12 (or exit). Reliability and validity were analyzed using Classical Test Theory (item-total correlations and internal consistency) and correlations between the CDRS-R and other outcomes. Results: Adolescents (n=145) were evaluated at screening; 113 (77.9%) met criteria for major depressive disorder, 8 (5.5%) had subthreshold depressive symptoms, and 24 (16.6%) had minimal depressive symptoms. Ninety-four adolescents had a baseline visit after 1 week, and 88 were treated with fluoxetine. Internal consistency for the CDRS-R was good at all three visits (screening: 0.79; baseline: 0.74; exit: 0.92), and total score was highly correlated with global severity (r=0.87, 0.80, and 0.93; p<0.01). Only exit CDRS-R score was significantly correlated with global functioning (Children's Global Assessment Scale; r=-0.77; p<0.01). Reductions on the CDRS-R total score were highly correlated with improvement scores at exit (Clinical Global Impressions-Improvement; r=-0.83; p<0.01). Conclusions: The results demonstrate good reliability and validity in adolescents with depression.

UR - http://www.scopus.com/inward/record.url?scp=78650645172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650645172&partnerID=8YFLogxK

U2 - 10.1089/cap.2010.0063

DO - 10.1089/cap.2010.0063

M3 - Article

VL - 20

SP - 513

EP - 516

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 6

ER -